News

Nike's Earnings Forecast: What Investors Should Expect

Nike's Earnings Forecast: What Investors Should Expect

Nike's Earnings Forecast: What to Expect

Nike (NYSE:NKE) is on the brink of releasing its quarterly earnings report, slated for December 18, 2025. This announcement is generating considerable interest among investors eager to glean insights on the company's financial performance and future direction.

Projected Earnings Per Share

Analysts are anticipating that Nike will report an earnings per share (EPS) of $0.37. However, the excitement doesn't just stem from this figure; investors are also looking for indications that the company might surpass this expectation.

Market Reactions to Previous Earnings

Understanding Past Performance

In the prior quarter, Nike's EPS exceeded expectations by $0.22, resulting in a notable 6.41% increase in its share price the following day. Such performance highlights the potential volatility that earnings reports can introduce into stock prices.

Historical Earnings Performance Exploration

Reflecting on Nike's historical performance, here's an overview:

Current Stock Performance Insights

As of mid-December, shares of Nike were trading at $67.12, marking a 12.94% decline over the past year. This trend could leave some long-term investors feeling uneasy as the company prepares for its earnings release.

Analyst Predictions and Market Sentiment

Consensus Rating Breakdown

Staying informed about the sentiments and expectations surrounding Nike is crucial for investors. Currently, Nike holds a consensus rating of Neutral from 20 analysts, with an average one-year price target of $79.50, suggesting a potential upside of 18.44% from current levels.

Peer Comparison of Analysts' Ratings

When comparing Nike with its competitors in the athletic wear market, it's essential to evaluate their performance as well. The ratings and price targets for significant industry players include:

  • On Holding is seen as an Outperform, with an average price target forecast of $61.65, suggesting an 8.15% downside.
  • Deckers Outdoor is favored with a Buy rating, projecting a strong potential upside of 68.92% with a price target set at $113.38.
  • Birkenstock Holding is similarly rated as Outperform, with a minor upside potential of 0.72% expected with a price target set at $67.60.

Analyzing Financial Metrics

Key Takeaways from Recent Market Analysis

During a recent peer analysis, various metrics have been collected for Nike and its competitors, revealing useful insights into their positions within the industry:

CompanyConsensusRevenue GrowthGross ProfitReturn on Equity
NikeNeutral1.13%$4.94B5.45%
On HoldingOutperform24.95%$522.20M8.09%
Deckers OutdoorBuy9.11%$803.82M10.87%
Birkenstock HoldingOutperform12.45%$384.08M4.76%

Nike currently holds a neutral consensus among its peers but ranks lower in revenue growth and profitability metrics, indicating room for improvement.

Understanding Nike's Business Framework

As the world's leading athletic footwear and apparel brand, Nike boasts a broad portfolio, with footwear comprising about two-thirds of its total sales. Key categories include basketball, running, and football (soccer). The company operates globally through various channels, including company-owned, franchised, and e-commerce platforms across over 40 countries. Despite being a market leader, Nike outsources a majority of its production to more than 30 countries.

Nike's Financial Health Assessment

Detailed Financial Overview

Focusing on key financial metrics:

Market Capitalization: Nike's substantial market capitalization positions it favorably within the industry, showcasing its notable market presence.

Revenue Growth: Recent financial performance reveals a revenue growth rate of 1.13% as of late August 2025, slightly trailing its competitors in the Consumer Discretionary sector.

Profitability Metrics: Nike's net margin is impressive at 6.2%, emphasizing effective cost management and profitability. In addition, its ROE stands at 5.45%, showcasing a robust utilization of equity.

Debt Analysis: Nike's debt-to-equity ratio of 0.82 suggests a relatively high leverage, prompting a need for careful financial management moving forward.

Frequently Asked Questions

What is Nike's anticipated EPS for the upcoming earnings report?

Nike is expected to report an earnings per share (EPS) of $0.37 for the quarter.

How did Nike's stock perform after its last earnings release?

Following the last quarter's earnings release, Nike's stock rose by 6.41% due to an EPS beat of $0.22.

What is the current stock price of Nike?

The last recorded stock price of Nike was $67.12 as of December 16.

How does Nike's performance compare to its peers?

Nike has a neutral consensus rating among analysts but lags in revenue growth compared to competitors like Deckers Outdoor and On Holding.

What are analysts' ratings for Nike?

Analysts generally rate Nike with a consensus rating of Neutral, with an average price target of $79.50, signaling potential upside.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 23

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 28

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 34

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 26

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 38

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Westgate Energy's Drilling Accomplishments and Financial Update

Updated Category News Views 106

Overview of Recent Developments Westgate Energy Inc. (TSXV: WGT) has released its latest financial results along with updates on its three well drilling program. The Company is thrilled to share positive advancements since it has successfully filed its unaudited financial and operational outcomes covering a significant quarter in its operations. Financial Highlights The...

Continue Reading
Warren Buffett's Investment Strategy: A Guide for Investors

Updated Category News Views 2908

Insights into Buffett's Investment Philosophy Warren Buffett is a name that resonates with wise investing. Over the years, he’s built his reputation on a foundation of simplicity and strategic insight. While many contemporary investors chase after fleeting trends, Buffett sticks to the fundamentals, offering a timeless roadmap for achieving long-term success in the...

Continue Reading
TeleRare Health Introduces Virtual Genetic Consults for Patients

Updated Category News Views 132

TeleRare Health Launches Virtual Genomic Consultation Service TeleRare Health has proudly announced the commencement of its Virtual Genomic Consults, providing immediate support for patients facing challenges with rare diseases and genetic conditions. This innovative initiative is particularly beneficial for those navigating the complex world of rare and genetic disorders...

Continue Reading
BrowserStack Unveils Major Employee Stock Ownership Program

Updated Category News Views 90

BrowserStack Launches $125 Million ESOP and Share Buyback BrowserStack, a leader in software testing solutions, has made waves with their announcement of a substantial $125 million Employee Stock Ownership Plan (ESOP) and share buyback program. Benefiting over 500 current and former employees along with early investors, this initiative marks the company's third buyback,...

Continue Reading
Insight into Banijay Group's Weekly Share Activities

Updated Category News Views 164

Banijay Group Share Transactions Overview Banijay Group N.V. is a name that resonates within the global entertainment industry, orchestrating an array of transactions that reveal its market dynamics. Recently, the company reported various share transactions conducted between June 23 and June 30. This disclosure aligns with the authorization granted during the recent...

Continue Reading